Executive Summary
Eco Science Solutions Inc (ESSI) reported a volatile QQ1 2025 performance with no disclosed revenue and a clear cash burn trajectory. The company posted an operating loss of -$276,063 and a net loss of -$294,613 for the quarter, alongside a negative free cash flow of -$82,816 and only $1,573 in cash at period end. The balance sheet is markedly stressed, with total current liabilities of $15.8567 million against total current assets of just $1.573 thousand, and stockholders’ equity deeply negative at -$15.756 million. The company did incur R&D and G&A expenses totaling $276,063, including $83,872 in R&D and $192,191 in G&A, indicating continued investment in product and platform development despite an absence of recognized revenue in the quarter.
Liquidity and solvency dynamics dominate the near-term risk profile. Net debt stood at approximately $6.673 million, and interest expense of $18,550 amplified the working-capital pressure. The company’s liquidity ratios are effectively nil (current/quick/cash ratios all around 0.0000992), signaling an extreme need for external financing, strategic partnerships, or revenue recognition improvements to stabilize financial footing.
On the potential upside, ESSI operates in a niche cannabis/hemp industry software space via its Herbo enterprise software suite, which may offer scalable SaaS revenue as the market matures and customer deployment expands. However, given the current earnings trajectory, negative equity, and weak liquidity, the investment thesis is highly contingent on material improvements in revenue generation, cost control, and/or successful financing that can unlock operating flexibility. Absent a credible path to accelerating revenue or securing meaningful liquidity, ESSI presents a high-risk profile with limited near-term visibility into earning power.
Key Performance Indicators
QoQ: 15.45% | YoY:-120.80%
QoQ: 16.07% | YoY:-118.80%
Key Insights
Revenue: not disclosed in QQ1 2025 data; Gross Profit: not disclosed; Operating Income: -$276,063.00 (YoY growth: 59.15%; QoQ growth: 16.71%),...
Financial Highlights
Revenue: not disclosed in QQ1 2025 data; Gross Profit: not disclosed; Operating Income: -$276,063.00 (YoY growth: 59.15%; QoQ growth: 16.71%),
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Operating Income |
-276.06K |
59.15% |
16.71% |
| Net Income |
-294.61K |
-120.80% |
15.45% |
| EPS |
-0.01 |
-118.80% |
16.07% |
Key Financial Ratios
operatingCashFlowPerShare
$-0
Management Commentary
No earnings-call transcript was provided in the supplied data. As a result, management commentary, strategic remarks, and forward-looking guidance from an earnings call are not captured here. Key qualitative insights and quotes from management could not be sourced from the provided materials.
No earnings call transcript was provided in the dataset.
— N/A
No quotes available from management in the provided materials.
— N/A
Forward Guidance
There is no explicit forward guidance in the presented data. The lack of reported revenue for QQ1 2025 and the pronounced cash burn imply that any near-term guidance would likely hinge on either a revenue ramp in the Herbo platform, cost-reduction initiatives, or a strategic financing event. Investors should monitor: (a) any announced customer wins or deployments that could translate into revenue, (b) changes in cost structure (especially operating expenses), and (c) cash runway and potential financing arrangements that could extend liquidity beyond the current $1.57k cash balance. Management commentary, if disclosed in subsequent filings or calls, should be weighed for credibility in addressing the company’s liquidity and path to profitability.